Open Access

Alterations in neuronal morphology and synaptophysin expression in the rat brain as a result of changes in dietary n-6: n-3 fatty acid ratios

  • Toktam Hajjar1,
  • Yong Meng Goh1, 2Email author,
  • Mohamed Ali Rajion1,
  • Sharmili Vidyadaran3,
  • Tan Ai Li1 and
  • Mahdi Ebrahimi1
Lipids in Health and Disease201312:113

https://doi.org/10.1186/1476-511X-12-113

Received: 28 March 2013

Accepted: 24 July 2013

Published: 26 July 2013

Abstract

Background

Polyunsaturated fatty acids (PUFA) play important roles in brain fatty acid composition and behavior through their effects on neuronal properties and gene expression. The hippocampus plays an important role in the formation of memory, especially spatial memory and navigation. This study was conducted to examine the effects of PUFA and specifically different dietary n-6: n-3 fatty acid ratios (FAR) on the number and size of hippocampal neurons and the expression of synaptophysin protein in the hippocampus of rats.

Methods

Forty 3-week old male Sprague–Dawley rats were allotted into 4 groups. The animals received experimental diets with different n-6: n-3 FAR of either 65:1, 26.5:1, 22:1 or 4.5:1 for 14 weeks.

Results

The results showed that a lowering dietary n-6: n-3 FAR supplementation can increase the number and size of neurons. Moreover, lowering the dietary n-6: n-3 FAR led to an increase in the expression of the pre-synaptic protein synaptophysin in the CA1 hippocampal subregion of the rat brain.

Conclusions

These findings support the notion that decreasing the dietary n-6: n-3 FAR will lead to an intensified hippocampal synaptophysin expression and increased neuron size and proliferation in the rat brain.

Keywords

n-3 polyunsaturated fatty acid Neuronal morphology Synaptophysin Hippocampus Rats

Background

The hippocampus is one of the main regions of the brain which monitors learning and memory processing [1]. It is also responsible for spatial memory and plays important roles in cognition. Memory and learning are first acquired by specialized CA1 cells located in the hippocampal region, processed by CA2 cells which are responsible for the long term potentiation and retention of memories. The CA3 cells in turn are responsible for memory plasticity and re-learning abilities [2]. It is thus justified to conclude that the CA1, CA2 and CA3 subregions are crucial in spatial memory [3]. Spatial memory is important to animals as it enables them to locate foods, mates and defends their territories which are crucial for species survival [4]. The adult hippocampus undergoes many types of plasticity including neurogenesis [5], alteration in the morphology of the cells [6] and changes in synaptic strength [7]. Functions of the hippocampus such as learning and memory rely on this plasticity [8]. Different expressions of proteins involved in neurotransmission at the synapses are considered as the markers of neural plasticity. Synaptophysin is a presynaptic membrane protein essential for neurotransmission in hippocampal neurons [9]. It is one of the most widely used protein markers of synaptic plasticity in the brain [10, 11]. Loss of this pre-synaptic vesicle protein in the hippocampus correlates with the cognitive decline in Alzheimer’s disease [11].

Studies have shown that PUFA supplementation is associated with an over-expression of synaptophysin in the hippocampus [12, 13]. The n-3 PUFA incorporated into the neuron membrane increase synaptic protein expression, resulting in an increased dendritic spine formation, neurite outgrowth, synaptogenesis, and neurogenesis to strengthen the hippocampal synaptic plasticity and protect the neurons [14]. The n-3 PUFA play an important role in neurogenesis and neurite outgrowth, and also influences the neural membrane biogenesis [15]. Previous studies have shown that docosahexaenoic acid (22:6 n-3; DHA) enhanced neurite outgrowth of hippocampal and cortical neurons [16] and a deficiency of n-3 fatty acids decreases the cell body size of neurons in the hippocampus and hypothalamus, and decreases the complexity of dendritic arborizations on cortical neurons [17]. On the other hand, it has been shown that the larger perikaryal size is accompanied by an increased terminal density, and this combination is positively correlated with an improvement of memory [18]. Membrane function is highly dependent on membrane fluidity and integrity, which in turn are dependent on the lipid composition of the lipid bilayer [19]. Changes in the PUFA content of the neural membrane influence membrane fluidity, control the physiological functions of the brain, and also regulate synthesis and functions of brain neurotransmitters resulting in changes in synaptic plasticity and spatial cognition [20, 21].

Fatty acids are crucial factors that determine the structure and function of biological membranes, including membranes in the nervous system. The brain has a higher lipid amount than any other organ in the body except adipose tissue. Neuronal membranes contain high concentrations of n-3 and n-6 PUFA [22]. Since dietary n-3 PUFA contribute to the construction and maintenance of the brain [23], they are also required for optimal cognitive performance [24]. In fact, our earlier report showed that rats fed with increasingly higher levels of n-3 PUFA vis-à-vis n-6 PUFA demonstrated marked improvement in cognitive, as well as spatial learning abilities [25]. These results pointed to the essentiality of n-3 PUFA in brain biochemistry, physiology, and functioning, and hence in cognitive performances during development [26]. There is a close interaction between PUFAs and the concentrations of various neurotransmitters in the brain that have relevance to long term potentiation (LTP) and memory formation [27]. A balance exists between various neurotransmitters in the brain, where a decrease in the levels of dopamine and serotonin may lead to an enhancement of the level of gamma-aminobutyric acid (GABA) and this, in turn, may contribute to learning deficits [27]. Several studies have shown that monoaminergic and cholinergic systems are influenced by chronically deprived n-3 PUFA during development in rodents [28]. In general, metabolism and function in the brain, especially neurotransmission, depend on preserving a homeostatically balanced concentration of n-3 and n-6 PUFA [29]. There is evidence to suggest that PUFA can enhance acetylcholine (ACH) release, which in turn may augment the events that facilitate memory and improvement of the learning ability [30], and prevent apoptosis of neurons [31]. The ACH is the principal vagal neurotransmitter and a known component of the parasympathetic nervous system [32]. This neurotransmitter modulates synaptic plasticity and LTP, which is a key component of memory consolidation, whereby the PUFA can improve the learning ability in rats [27].

The PUFAs also inhibit the production of the neurotoxic cytokine tumor necrosis factor (TNF), interleukin-1 (IL-1), and IL-6 and enhance nitric oxide (NO) synthesis, thereby preventing neuronal apoptosis and facilitate memory improvement and consolidation [27]. Thus, it is clear that PUFAs can enhance neuronal survival by protecting against the peroxidative damage of lipids and proteins in brains and attenuate neuron loss, resulting in an improved cognitive function [16]. Interestingly PUFA are also important natural agonists for Peroxisome Proliferator-Activated Receptors (PPAR). PPAR’s are subfamily members of the nuclear receptor super family, and are found extensively in neurons and microglials, two cell types that are crucial for neuronal remodeling [33]. PPAR’s have been reported to have pronounced neuroprotective and anti-inflammatory properties [34, 35]. Therefore the upregulation of PPAR activities in the brain as a result of n-3 and n-6 supplementation reported in our earlier study [25], would have profound effects on the morphology of neurons. In view of the importance of n-3 PUFA to the central nervous system, particularly in the hippocampal region, this study was conducted to determine the impact of an increase of n-3 PUFA on the possible microscopic changes to the neuron morphology in the hippocampus. This is crucial as the retention of memory involves both chemical and morphological changes in the hippocampus we postulated that improved cognitive function that was reported earlier [25] may have been associated with both chemical and morphological changes brought upon by the PUFA supplementation in the hippocampus. These would have enabled us to correlate the potential positive outcome of neural plasticity as a result of n-3 PUFA supplementation, and n-3 PUFA’s potential roles in facilitating memory and learning. To address this objective, the size and number of neurons in the CA1 and CA3 hippocampus were analyzed. In this study, it was also determined whether different dietary n-6: n-3 FAR affected the hippocampal expression of synaptophysin, which is an essential factor for synaptic plasticity in the rat brain.

Results

Fatty acid profiles of the hippocampus

Brain Hippocampus fatty acid profiles as percentage of total fatty acids in the CTRL and fish oil and soybean oil supplemented groups are shown in Table 1.
Table 1

Fatty acid profile in rat hippocampus after 12 weeks of feeding trial (Mean ±1 SE)

 

Groups

Fatty acid

CTRL

LMO

MMO

HMO

Myristic Acid (14:0)

1.85 ± 0.14a

2.07 ± 0.26a

3.18 ± 0.07b

2.25 ± 0.44ab

Myristoleic Acid (14:1)

0.83 ± 0.11b

1.43 ± 0.30b

0.00 ± 0.00a

0.00 ± 0.00a

Palmitic Acid (16:0)

23.42 ± 0.79

22.40 ± 0.65

21.38 ± 0.59

22.27 ± 0.93

Stearic Acid (18:0)

22.77 ± 0.21

22.82 ± 0.35

22.23 ± 0.40

22.78 ± 0.64

Oleic Acid (18:1)

19.56 ± 0.34

19.10 ± 0.35

19.59 ± 1.28

20.17 ± 1.31

Linoleic Acid (18:2 n-6)

0.73 ± 0.10

0.92 ± 0.08

0.66 ± 0.11

0.81 ± 0.23

Linolenic Acid (18:3 n-3)

1.47 ± 0.11

1.81 ± 0.21

1.42 ± 0.41

1.44 ± 0.13

Nervonic Acid (24:1)

4.81 ± 0.14ab

4.86 ± 0.59ab

5.37 ± 0.30b

3.42 ± 0.57a

Arachidonic Acid (20:4 n-6)

10.91 ± 0.52

9.46 ± 0.51

9.28 ± 0.51

7.65 ± 0.32

Eicosapentaenoic acid (20:5n-3)

1.02 ± 0.21b

1.32 ± 0.34b

1.55 ± 0.43ab

2.45 ± 0.15a

Docosapentaenoic acid (22:5n-3)

0.13 ± 0.03

0.32 ± 0.02

0.26 ± 0.01

0.41 ± 0.04

Docosahexaenoic acid (22:6 n-3)

12.50 ± 0.62a

13.49 ± 0.70ab

13.95 ± 1.46ab

15.75 ± 0.38b

Total SFA

48.04 ± 0.71

47.30 ± 0.50

46.79 ± 0.46

47.30 ± 1.14

Total MUFA

25.20 ± 0.46

25.39 ± 1.02

24.96 ± 1.37

23.59 ± 1.49

Total n-3 PUFA

15.12 ± 0.66a

16.94 ± 0.51ab

17.18 ± 1.05ab

20.05 ± 0.27b

Total n-6 PUFA

11.64 ± 0.42

10.19 ± 0.44

10.01 ± 0.58

8.38 ± 0.49

Total PUFA

26.76 ± 1.03

27.13 ± 1.65

27.19 ± 1.98

28.43 ± 1.76

(n-6):(n-3)

0.77 ± 0.02b

0.60 ± 0.01ab

0.58 ± 0.05ab

0.42 ± 0.03a

UFA:SFA

1.09 ± 0.03

1.12 ± 0.02

1.14 ± 0.02

1.15 ± 0.05

PUFA:SFA

0.56 ± 0.03

0.57 ± 0.02

0.58 ± 0.03

0.60 ± 0.01

a, b notations differ significantly within rows at P < 0.05.

CTRL: control group, LMO: low menhaden oil, MMO: medium menhaden oil and HMO: high menhaden oil. SFA: sum of C14:0, C16:0, C18:0. MUFA: sum of C14:1, C18:1, C24:1. Total n-3PUFA: sum of C18:3n-3, C20:5n-3, C22:5n-3, C22:6n-3. Total n-6PUFA: sum of C18:2n-6, C20:4n-6. (n-6): (n-3): Total n-6PUFA (C18:2n-6, C20:4n-6): Total n-3PUFA (C18:3n-3, C20:5n-3, C22:6n-3).

Supplementation of n-3 PUFA from fish oil significantly increased DHA content in the brain (P < 0.05) in HMO fed animals. The trend of the DHA concentration in the brain followed the order of HMO > MMO > LMO > CTRL (Table 1). These values were 15.75%, 13.95%, 13.49%, and 12.50% in HMO, MMO, LMO, and CTRL animals, respectively.

The amount of AA in the brain of CTRL animals was higher compared to the treatment groups (Table 1).

The fish oil fed animals had more total n-3 PUFA than CTRL groups in their brains (Table 1). A 7-fold increase in n-3 PUFA in MMO diet resulted in 13.62% increase in the brain n-3 PUFA. While in response to the 26-fold increase of n-3 PUFA diet, content of brain n-3 PUFA in HMO rats increased by 32.60% (P < 0.05).

The n-6 PUFA was lower in fish oil and soybean oil fed animals, the levels were in the decreasing order of LMO > MMO > HMO although they were not significantly different (Table 1). However, the fish oil and soybean oil fed animals had less n-6: n-3 fatty acid ratios in their brains when compared to CTRL groups. Based on Table 1, the HMO animals had the lowest n-6: n-3 fatty acid ratio, 0.42, which was significantly different (P < 0.05) from CTRL (0.77), MMO (0.55) and LMO (0.60) groups (Table 1).

Size and number of neurons

Table 2 illustrates the size of the neurons in the CA1 layer of the hippocampus, which has an important role in spatial memory. In the Control (CTRL), low menhaden oil (LMO) and medium menhaden oil (MMO) groups, the CA1 neurons were significantly smaller compared to the neurons in the HMO group. The average size of neurons in the hippocampus CA1 in high menhaden oil (HMO) rats was 79.32 μm2 ± 3.83, while the area of these neurons in other groups ranged from 56.51- 59.97 μm2. Thus, the size of CA1 neurons was larger by 40% in the HMO group compared to the CTRL group (P < 0.05). The difference in neuron size between the MMO and LMO rats was not significantly different (P > 0.05) compared to the CTRL group (Table 2). The size of neurons in CA3 (89.91- 99.66 μm2) was larger than CA1 (56.51-79.32 μm2). There was no significant difference (P > 0.05) in the size of neurons in the CA3 layer in the LMO, MMO and HMO rats compared to CTRL rats.
Table 2

Neuron size (μm 2 ) in the hippocampus after 12 weeks of feeding trial (Mean ± SE)

 

Group

Hippocampal CA neurons

CTRL

LMO

MMO

HMO

CA1

56.51 ± 2.42a

57.83 ± 2.01a

59.97 ± 2.69a

79.32 ± 3.83b

CA3

89.91 ± 3.09

85.56 ± 4.47

90.54 ± 4.25

99.66 ± 6.15

a, b notations differ significantly within rows at P < 0.05.

CTRL: control group, LMO: low menhaden oil, MMO: medium menhaden oil and HMO: high menhaden oil.

Table 3 illustrates the number of neurons in the hippocampus. The mean number of CA1 neurons of all supplemented groups was significantly higher than the CTRL group (P < 0.05). However, the numbers of neurons of the hippocampal CA3 region in the supplemented groups were not significantly different compared to CTRL rats. The light micrographs of the hippocampus from CTRL rats and supplemented groups are shown in Figure 1.
Figure 1

Light micrograph of hippocampal CA1 neurons in rats. CTRL (A), LMO (B), MMO (C) and HMO (D). Note that the size of neurons in HMO rats (D) was larger than the other groups.

Table 3

Neuron number in the hippocampus after 12 weeks of feeding trial (Mean ± SE)

 

Group

Hippocampal CA neurons

CTRL

LMO

MMO

HMO

CA1

11.48 ± 0.38a

13.60 ± 0.43b

13.95 ± 0.90b

13.13 ± 1.07b

CA3

8.43 ± 0.39a

8.54 ± 0.38a

8.32 ± 0.21a

10.11 ± 1.10a

a, b notations differ significantly within rows at P < 0.05.

CTRL: control group, LMO: low menhaden oil, MMO: medium menhaden oil and HMO: high menhaden oil.

Synaptophysin immunohistochemistry

To identify the amount of synaptophysin protein which plays a critical role in synaptic plasticity in the hippocampal CA1 neurons, a immunohistochemistry method was performed on the right hippocampal region of both unsupplemented and supplemented groups. Figure 2 illustrates the effect of dietary fatty acids and different n-6: n-3 FAR on the expression of synaptophysin in the hippocampal region. The intensity of this pre-synaptic protein in the CA1 neurons was increased in animals supplemented with higher n-3 PUFA, i.e. in groups (MMO, HMO) by reducing the n-6: n-3 ratio in the diet. Indeed, the rate of expression of synaptophysin protein can be observed by the change in the intensity of the brown color in micrographs stained with IHC technique. The current results showed that the area of regions with high intensity was 4% in HMO rats. This value for MMO, LMO and CTRL groups was 2%, 0.3% and 0.1%, respectively. Therefore, the HMO and MMO rats which were fed higher amounts of fish oil showed a greater intensity of the brown color compared to the LMO and CTRL groups.
Figure 2

Light micrograph of the CA1 rat hippocampus. Note that the intensity of the synaptophysin (arrows) was higher in MMO (C) and HMO (D) compared to group LMO (B) and CTRL (A).

Discussion

The high hippocampal concentration of total n-3 PUFA in the HMO group observed in this study correlated with the significantly higher levels of n-3 PUFA in this diet. DHA supplied via fish oil dietary was effective in enriching brain tissue fatty acids; the DHA content of HMO group was 20% higher than that of the CTRL group in our study. At the same time, AA decreased below the level of CTRL rats in LMO and HMO fed animals. Our results, concerning the brain balance between DHA and AA induced by dietary n-3 fatty acids, corroborate with some reports [36] which have demonstrated an increase in DHA with a decrease in AA in n-3-rich diet fed animals. The n-3 fatty acid content of the brain is high and has been suggested to be the important factor in brain function as the membrane phospholipid fatty acid composition and configuration of neurotransmitter receptors [37, 38].

Memory improvement via PUFA supplementation might be due to the improved membrane fluidity that can affect synaptic plasticity, neurotransmission and synaptogenesis [39]. An increase in the PUFA level will result in fluidization of the neuronal membrane [40]. The neural membrane functions to regulate membrane-bound enzymes, control ionic channel activity, modify the number and affinity of receptors and regulate the production of neurotransmitters which are dependent on the membrane fluidity [40]. Collectively, these could be translated into more efficient signal transduction and sustenance within the entire neuronal network responsible for memory creation and retention. Since the n-3 fatty acids generate changes in membrane fluidity, enzyme activity, and gene expressions, the amount of these fatty acids in the membrane may be a key factor affecting the cognitive and sensitive components, and changing the lipid signaling [40]. The DHA which is the most important n-3 PUFA in neural membranes, is crucial for the maintenance and restoration of neural membrane function and the n-6:n-3 balance in the membrane is important for the neurotransmission and neuroprotection [41].

Our data suggest that the neuron size and number increased in the hippocampus with increasing n-3 PUFA supplementation. In general, the hippocampal neuron size in the HMO rats was larger than those fed lower levels of n-3 PUFA (MMO and LMO). The number of neurons also increased in the supplemented rats. The current results suggest that the neurons in the brains of rats fed the n-3 PUFA supplemented diet developed at a faster rate. These findings are consistent with previous reports by Su [14] on the effects of n-3 PUFA on neurogenesis. The dietary n-3 PUFA can affect the morphological parameters in the hippocampus such as the size of neurons, as previous studies have reported that a deficiency of brain DHA as a source of n-3 PUFA led to a reduction in the neuronal size in the CA1 region of the hippocampus [17]. The increase in the cell body of neurons, likely reflecting an increased synthesis and the concentration of neurofilaments can cause behavioral changes [42]. For example, the increase in cell size and numbers were accompanied by increases in the size of terminal fields and density of boutons [43, 44]. Such expansion of the terminals and intensity of vesicle synapses are likely to affect memory formation.

The morphometric changes affecting circuits that convey cortically derived information is critical for hippocampal learning [45]. Memory formation is based on the process of neurotransmission, and one possible explanation of the improvement of neurotransmission may be a consequence of synaptogenesis [13]. Since the neurotransmitter release requires fusion of the synaptic vesicle with the synaptic membrane, a decrease in the membrane fluidity may impair the synaptic transmission [46]. The PUFA with the aid of protein kinase C (PKC) may also contribute to trigger synaptogenesis [47]. Learning and memory formation correlate with modulation of neuronal activity that lead to changes in gene expression and synapse number [48]. Our data showed that the hippocampal neuron size in the HMO rats was larger than the other groups. Previous studies have also reported the decrease in neuron size of the hippocampus in the DHA-deficient diet groups [17]. The decrease in neuronal n-3 PUFA could decrease the nerve growth factor in the hippocampus and might result in a change the hippocampal neuron size [17, 24].

The PUFA augment the neurotransmitter ACh formation and release in the brain and the ACh modulates LTP and synaptic plasticity in neuronal circuits that are involved in learning and memory [27]. In the mammalian hippocampus, the LTP is associated with changes in expression of proteins involved in the induction of synaptic plasticity. The supplementation with DHA will increase synaptic plasticity and memory formation through an increase of specific pre- or post-synaptic proteins, which are essential for synaptic plasticity and memory strengthening [49].

In the present study using synaptophysin, a marker of synaptic density and synaptic vesicle formation, it was shown that n-3 PUFA supplementation was able to enhance synaptogenesis in the hippocampus. One possible explanation for the improvement of spatial memory may be a consequence of improved synaptic plasticity and neurotransmission through the enhancement of synaptophysin expression.

The current results showed that PUFA supplementation increased the amount of synaptophysin protein in the hippocampal neurons. Treatment groups with spatial learning improvement displayed increases in the intensity of synaptophysin immunohistochemical staining in the CA1. There is a correlation between behavior and synatophysin intensity in the hippocampus that receives direct cortical inputs [45]. Synaptophysin is the major protein of the synaptic membrane and may play an important role as a channel in synaptic vesicle exocytosis, e.g. in neurotransmitter release. Thus, the early increase in synaptophysin expression may reflect an upregulation of synaptic functions and may be related to the release of the neurotransmitters. Since synaptophysin and other synaptic vesicle proteins have been implicated in the mechanisms of cellular plasticity underlying learning [50], an increase in the expression of this protein might improve memory formation. Synaptophysin is a reliable indicator of synaptic plasticity, and has previously been demonstrated to correlate well with the loss of cognitive function in mouse models with neurodegeneration and in humans with Alzheimer’s disease. The interpretation of these results was based on the observation that these alterations in synaptophysin staining were apparent among the rats with increased spatial learning. In the present study, the effect of increased brain n-3 fatty acids on hippocampus morphology was assessed based on the changes in the amount of presynaptic protein synaptophysin in the CA1 hippocampal neurons. The results indicated that the expression of synaptophysin was increased in the rats supplemented with higher levels of n-3 fatty acids. The PUFA have good protective effects on synaptophysin [51], resulting in increased synaptophisin expression among groups supplemented with increased n-3 PUFA. Since cognitive function is linked to alterations in presynaptic proteins, the increase in synaptophysin may enhance synaptic plasticity leading to the improvement of memory formation.

Conclusions

In conclusion, this study demonstrated that diets supplemented with higher levels of menhaden fish oil improve spatial memory by incorporating abundant dietary n-3 fatty acids into the membrane phospholipids of the brain. These fatty acids would affect neuronal function by changing the physical properties of the membrane, and influence a variety of physiological membrane functions that depend on the membrane fluidity. This raises the possibility of using natural compounds such as fish oil to improve mental ability such as spatial memory. The alterations in neuronal morphology, biochemistry, and physiology associated with the increased brain n-3 PUFA might lead to the improvement of mental ability and memory.

Methods

Animals and diets

Forty individually housed male Sprague–Dawley rats weighing 200 ± 20 g were assigned randomly into four treatment groups of ten animals each namely the control group (CTRL), low menhaden oil (LMO), medium menhaden oil (MMO) and high menhaden oil (HMO). After a one week adaptation period, all the rats were fed the experimental diets for 14 weeks. They were maintained under a light/dark cycle 12/12 h at constant temperature (25 ± 2°C) and humidity (50–60%). The experiment was approved by the Institutional Animal Care and Use Committee (IACUC) of the Faculty of Veterinary Medicine, Universiti Putra Malaysia (approval UPM/FPV/PS/3.2.1.551/AUP-R66). All diets were prepared fresh and fed to the animals once daily at 0900 h at 10% of body weight with water available ad libitum.

The CTRL, LMO, MMO and HMO groups received standard pellet diets enriched with 7% (w/w) of butter, 0.23% (w/w) fish oil + 6.77% (w/w) soybean oil, 1% (w/w) fish oil + 6% (w/w) soybean oil, and 3.5% (w/w) fish oil + 3.5% (w/w) soybean oil, respectively. The fatty acid composition of treatment diets is presented in Table 4.
Table 4

Fatty acid profile of the experimental diets

 

Group

Fatty acid

CTRL

LMO

MMO

HMO

Caprylic Acid (8:0)

0.70

0.10

0.17

0.13

Capric Acid (10:0)

0.87

0.37

0.13

0.09

Lauric Acid (12:0)

6.05

0.06

0.06

0.05

Myristic Acid (14:0)

4.66

1.03

1.26

2.82

Myristoleic Acid (14:1)

0.27

0.07

0.10

0.10

Pentadecanoic Acid (15:0)

0.27

0.14

0.14

0.25

cis Pentadecenoic Acid (15:1)

0.10

0.11

0.05

0.09

Palmitic Acid (16:0)

28.11

14.60

15.16

16.47

Palmitoleic Acid (16:1)

0.84

1.14

1.53

3.93

Stearic Acid (18:0)

6.77

3.96

4.18

4.84

Oleic Acid (18:1n-9)

29.59

30.10

20.35

26.85

Linoleic Acid (18:2n-6)

17.78

40.39

40.37

31.94

α-Linolenic Acid (18:3n-3)

0.28

0.38

0.37

0.27

Arachidic Acid (20:0)

1.51

2.08

2.09

2.39

Arachidonic Acid (20:4n-6)

0.15

0.60

0.13

0.29

Eicosapentaenoic acid (20:5n-3)

0.00

0.61

0.92

3.40

Docosahexaenoic acid (C22:6n-3)

0.00

0.56

0.65

3.59

Total SFA

50.19

24.54

24.43

27.98

Total MUFA

31.54

32.73

33.03

32.29

Total n-3 PUFA

0.28

1.56

1.94

7.26

Total n-6 PUFA

17.99

41.16

40.59

32.47

(n-6): (n-3)

65.09

26.45

22.56

4.47

CTRL: control group, LMO: low menhaden oil, MMO: medium menhaden oil and HMO: high menhaden oil.

SFA: sum of C8:0, C10, C12:0, C14:0, C15:0, C16:0, C18:0, C20:0.

MUFA: sum of C14:1, C15:1, C16:1, C18:1.

Total n-3PUFA: sum of C18:3n-3, C20:5n-3, C22:6n-3.

Total n-6PUFA: sum of C18:2n-6, C20:4n-6.

(n-6): (n-3): Total n-6PUFA (C18:2n-6, C20:4n-6): Total n-3PUFA (C18:3n-3, C20:5n-3, C22:6n-3).

Fatty acid analysis

Total fat from the experimental diets and brain were extracted according to the methods described by [52] and modified by [53]. The experimental dets approximately 2 g were mixed with of chloroform-methanol (2:1, v/v) containing butylated hydroxytoluene as antioxidant. Then, fatty acids methyl esters (FAME) were preapared using potassium hydroxide and boron trifluoride (BF3) (Sigma Chemical Co. St. Louis, Missouri, USA). The FAME were separated by with an Agilent 7890A Series GC system (Agilent Technologies, Palo Alto, CA, USA) using a 30 m × 0.25 mm ID (0.20 μm film thickness) Supelco SP-2330 capillary column (Supelco, Inc., Bellefonte, PA, USA). One microlitre of FAME was injected into the chromatograph, equipped with a split/splitless injector and a flame ionization detector (FID). The injector temperature was programmed at 250°C and the detector temperature was 300°C. The column temperature program initiated runs at 100°C, for 2 min, warmed to 170°C at 10°C/min, held for 2 min, warmed to 200°C at 7.5°C/min, and then held for 20 min to facilitate optimal separation. Identification of fatty acids was carried out by comparing relative FAME peak retention times of samples to standards obtained from Sigma (St. Louis, MO, USA).

Brain tissue sampling and processing

At the end of the 14-week feeding trial the rats were deeply anesthetized by intraperitoneal injection of ketamine-xylazine (Ketamine 50 mg/kg & Xylazine 10 mg/kg) before the diaphragm muscle was severed. They were then perfused transcardially with cold normal saline (0.9% NaCl), followed by 4% paraformaldehyde in 0.1 m phosphate buffer (PFA, pH 7.4) for 20 min. The whole brain was then removed and post-fixed for 24 h at 4°C. The right hemisphere of the brain was rinsed and transferred to 30% sucrose in 0.1 m phosphate buffer (pH 7.4) at 4°C until saturated. Coronal sections (20 μm) were cut on a cryostat at −22°C and stored at −80°C until immunohistochemistry (IHC) processing. To visualize the morphology of the neurons, the left hemispheres of the brains were dehydrated through graded alcohols and xylene, and embedded in paraffin. Five-micrometer sections were cut and hematoxylin and eosin were used.

The nomenclature and nuclear boundaries used in this study were based on the atlas of Paxinos and Watson [54]. For the dorsal hippocampus, we used sections ranging from −2.5 to −3.5 mm from Bregma [54].

Morphological measurements: number and size of neurons

Regions of the hippocampus selected for morphological measurements in coronal sections [54] were lying close to the middle of the anterioposterior extent of the brain. Neurons in 10 sections of the hippocampal area were measured from each rat. In each rat, the size and number of neurons in CA1 and CA3 layers at the septum (approximately −2.5 to −3.5 mm from Bregma) in the hippocampus based on the maps of Paxinos and Watson [54] were analyzed. The measuring of the size and number of neurons was performed using ImageJ software (version 1.44p, National Institute of Mental Health, Bethesda, Maryland, USA). The brain of five rats from each group was used and the area of neurons was measured in 10 sections from each rat. The hippocampal neurons were distinguished from the glia on the basis of their size and the presence of a large and relatively pale nuclei and well-defined Nissl material in their cytoplasm. Each neuron was visualized using an oil immersion objective at 100 × magnification.

Immunohistochemistry (IHC)

For synaptophysin IHC, sections were rinsed in 0.1 m phosphatebuffered saline (pH 7.4), blocked in 0.2% Triton X-100 (TX) and 5% normal donkey serum (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) for 1 hour at room temperature, and then incubated in monoclonal mouse antisynaptophysin (MAB5258; Chemicon, Temecula, CA, USA), diluted 1: 200 in 0.5% TX and 5% normal donkey serum for overnight at 4°C. This was followed by incubation in biotinylated horse antimouse IgG (1: 2, Vector Laboratories, Burlingame, CA, USA), 0.2% TX and 5% normal donkey serum for 1 h at room temperature and, after rinsing, was incubated with avidin–biotin–peroxidase complex (Vectastain kit; Vector Laboratories, Burlingame, CA, USA) for 1 h at room temperature. The sections were rinsed, reacted with 0.05% 3,3′- diaminobenzidine tetrahydrochloride (Sigma, St Louis, MO, USA) containing 0.01% H2O2 for 10 min. The sections were rinsed, mounted onto slides, dried, dehydrated and topped with cover slips. Synaptophysin staining was absent in control sections incubated without the primary antibody, confirming that the antibody was synaptophysin-specific.

Data analysis

The size and number of neurons in the hippocampus were compared across treatment groups using an analysis of variance procedure (ANOVA). Significant different means were then tested using the Tukey (the variances of the groups were equal) and Dunnett’s T3 (the variances of the groups were not equal) post hoc test for analyzing the size and number of neurons, respectively. Data was considered significantly different when P < 0.05.

Declarations

Acknowledgement

This study was supported by the Research University Grant Scheme (Vote No. 91734), Universiti Putra Malaysia.

Authors’ Affiliations

(1)
Department of Veterinary Preclinical Sciences, Universiti Putra Malaysia
(2)
Institute of Tropical Agriculture, Universiti Putra Malaysia
(3)
Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia

References

  1. Francis F, Koulakoff A, Boucher D, Chafey P, Schaar B, Vinet MC: Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron. 1999, 23: 247-256. 10.1016/S0896-6273(00)80777-1View ArticlePubMedGoogle Scholar
  2. Sydow A, Jeugd A, Zheng F, Ahmed T, Balschun D, Petrova O: Tau- induced defects in synaptic plasticity, learning and memory are revisable in transgenic mice after switching off the toxic tau mutant. Neuroscience. 2011, 31 (7): 2511-2525. 10.1523/JNEUROSCI.5245-10.2011View ArticlePubMedGoogle Scholar
  3. Kesner RP, Lee I, Gilbert P: A behavioral assessment of hippocampal function based on a subregional analysis. Rev Neurosci. 2004, 15: 333-351.View ArticlePubMedGoogle Scholar
  4. Barton RA: Neocortex size and behavioural ecology in primates. Proc R Soc London B. 1996, 263: 173-177. 10.1098/rspb.1996.0028.View ArticleGoogle Scholar
  5. Gould E, Beylin A, Tanapat P, Reeves A, Shors T: Learning enhances adult neurogenesis in the hippocampal formation. Natl Neurosci. 1999, 2: 260-265. 10.1038/6365. 10.1038/6365View ArticleGoogle Scholar
  6. Magarinos A, McEwen B, Flugge G, Fuchs E: Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neuro. 1996, 16: 3534-3540.Google Scholar
  7. Bliss T, Collingridge GA: Synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993, 361: 31-39. 10.1038/361031a0View ArticlePubMedGoogle Scholar
  8. McQuade JMS: PhD thesis. The involvement of DFF45 and c-Fos in hippocampal plasticity and function. 2002, USA: University of Cincinnati.Google Scholar
  9. Weimer RM, Jorgensen EM: Controversies in synaptic vesicle exocytosis. J Cell Sci. 2003, 116: 3661-3666. 10.1242/jcs.00687View ArticlePubMedGoogle Scholar
  10. Counts SE, Nadeem M, Lad SP, Wuu J, Mufson EJ: Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J Neuropathol Exp Neurol. 2006, 65: 592-601. 10.1097/00005072-200606000-00007View ArticlePubMedGoogle Scholar
  11. Reddy PH, Mani G, Park BS, Jacques J, Murdoch G, Whetsell JW: Differential loss of synaptic proteins in Alzheimer’s disease: implications for synaptic dysfunction. J Alzheimers Dis. 2005, 7 (2): 103-117.PubMedGoogle Scholar
  12. Solfrizzi V, Colacicco AM, D’Introno A, Capurso C, Torres F, Rizzo C: Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian longitudinal study on aging. Neurobiol Aging. 2006, 27: 1694-1704. 10.1016/j.neurobiolaging.2005.09.026View ArticlePubMedGoogle Scholar
  13. Venna VR, Deplanque D, Allet C, Belarbi K, Hamdane M, Bordet R: PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology. 2009, 34: 199-211. 10.1016/j.psyneuen.2008.08.025View ArticlePubMedGoogle Scholar
  14. Su HM: Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. J Nutr Biochem. 2010, 21 (5): 364-373. 10.1016/j.jnutbio.2009.11.003View ArticlePubMedGoogle Scholar
  15. Coti B, O’Kusky J, Innis SM: Maternal dietary n-3 fatty acid deficiency alters neurogenesis in the embryonic rat brain. J Nutr. 2006, 36: 1570-1575.Google Scholar
  16. Cao DH, Xu JF, Xue RH, Zheng WF, Liu ZL: Protective effect of chronic ethyl docosaehxaenoate administration on brain injury in ischemic gerbils. Pharmacol Biochem Behav. 2004, 79: 651-659. 10.1016/j.pbb.2004.09.016View ArticlePubMedGoogle Scholar
  17. Ahmad A, Moriguchi T, Salem N: Decrease in neuron size in docosahexaenoic acid- deficient brain. Pediatr Neurol. 2002, 26 (3): 210-218. 10.1016/S0887-8994(01)00383-6View ArticlePubMedGoogle Scholar
  18. Gustilo M, Markowska A, Breckler S, Fleischman C, Price D, Koliatsos V: Evidence that nerve growth factor influences recent memory through structural changes in septohippocampal cholinergic neurons. J Comp Neurol. 1999, 405: 491-507. 10.1002/(SICI)1096-9861(19990322)405:4<491::AID-CNE4>3.0.CO;2-NView ArticlePubMedGoogle Scholar
  19. Giraud MN, Motta C, Boucher D, Grizard G: Membrane fluidity predicts the outcome of cryopreservation of human spermatozoa. Hum Reprod. 2000, 15: 2160-2164. 10.1093/humrep/15.10.2160View ArticlePubMedGoogle Scholar
  20. Fukaya T, Gondaira T, Kashiyae Y, Kotani S, Ishikura Y, Fujikawa S: Arachidonic acid preserves hippocampal neuron membrane fluidity in senescent rats. Neurobiol Aging. 2007, 28: 1179-1186. 10.1016/j.neurobiolaging.2006.05.023View ArticlePubMedGoogle Scholar
  21. Okaichi Y, Ishikura Y, Akimoto K, Kawashima H, Toyoda-Ono Y, Kiso Y, Okaichi H: Arachidonic acid improves aged rats’ spatial cognition. Physiol Behav. 2005, 84: 617-623. 10.1016/j.physbeh.2005.02.008View ArticlePubMedGoogle Scholar
  22. Uauy R, Danqour AD: Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev. 2006, 64: 524-533.View ArticleGoogle Scholar
  23. Innis SM: Dietary omega 3 fatty acids and the developing brain. Review Literature Arts Americas. 2008, 1237: 35-43.Google Scholar
  24. Ikemoto A, Nitta A, Furukawa S: Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neurosci Lett. 2000, 285: 99-102. 10.1016/S0304-3940(00)01035-1View ArticlePubMedGoogle Scholar
  25. Hajjar T, Goh YM, Rajion MA, Vidyadaran S, Othman F, Farjam AS, Ebrahimi M: Omega 3 polyunsaturated fatty acid improves spatial learning and hippocampal Peroxisome Proliferator Activated Receptors (PPARα and PPARγ) gene expression in rats. BMC Neurosci. 2012, 13 (1): 109. 10.1186/1471-2202-13-109PubMed CentralView ArticlePubMedGoogle Scholar
  26. Bourre JM: Fatty acids, cognition, behavior, brain development, and mood diseases. Fatty acids in foods and their health implication. 2007, 935-954. New York: Marcel Dekker, Inc, 3.View ArticleGoogle Scholar
  27. Das UN: Can memory be improved? A discussion on the role of ras, GABA, acetylcholine, NO, insulin, TNF-a, and long-chain polyunsaturated fatty acids in memory formation and consolidation. Brain Dev. 2003, 25: 251-261. 10.1016/s0387-7604(02)00221-8View ArticlePubMedGoogle Scholar
  28. Chalon S: Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids. 2006, 75: 259-269. 10.1016/j.plefa.2006.07.005View ArticlePubMedGoogle Scholar
  29. Igarashi M, Ma K, Chang L, Bell JM, Rapoport SI: Rat heart cannot synthesize docosahexaenoic acid from circulating alpha -linolenic acid because it lacks elongase-2. Lipid Res. 2008, 49: 1735-1745. 10.1194/jlr.M800093-JLR200.View ArticleGoogle Scholar
  30. Hasselmo ME: Neuromodulation: acetylcholine and memory consolidation. Trends Cogn Sci. 1999, 3: 351-359. 10.1016/S1364-6613(99)01365-0View ArticlePubMedGoogle Scholar
  31. Lauritzen L, Hansen HS, Jørgensen MH, Michaelsen KF: The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res. 2001, 40 (1–2): 1-94.View ArticlePubMedGoogle Scholar
  32. Borovikova LV, Ivanova S, Zhang M: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000, 405: 458- 10.1038/35013070View ArticlePubMedGoogle Scholar
  33. Anna R, Carta Pisanu A: Modulating Microglia activity with PPAR-γ Agonists: a promising therapy for Parkinson’s disease?. Neurotox Res. 2013, 23 (2): 112-123. 10.1007/s12640-012-9342-7View ArticleGoogle Scholar
  34. Sun Y, Alexander SPH, Kendall DA, Bennett AJ: Cannabinoids and PPARa signalling. Biochem Soc Trans. 2006, 34 (6): 1095-1097. 10.1042/BST0341095View ArticlePubMedGoogle Scholar
  35. Zahra FH, Tasker RA: Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) activation confers functional Neuroprotection in Global Ischemia. Neurotoxicity Res. 2011, 19 (3): 462-471. 10.1007/s12640-010-9201-3.View ArticleGoogle Scholar
  36. Wainwright PE, Huang YS, Bulman-Fleming B, Dalby D, Mills DE, Redden P, McCutcheon D: The effects of dietary n-3/n-6 ratio on brain development in the mouse: a dose response study with long-chain n-3 fatty acids. Lipids. 1992, 27 (2): 98-103. 10.1007/BF02535807View ArticlePubMedGoogle Scholar
  37. Stevens LJ, Zentall SS, Abate ML: Omega-3 fatty acids in boys with behavior, learning and health problems. Physiol Behav. 1996, 59: 915-920. 10.1016/0031-9384(95)02207-4View ArticlePubMedGoogle Scholar
  38. Willats P, Forsyth JS, DiModugno MK: Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet. 1998, 352: 688-691. 10.1016/S0140-6736(97)11374-5View ArticleGoogle Scholar
  39. Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y: Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res. 2006, 56: 159-164. 10.1016/j.neures.2006.06.010View ArticlePubMedGoogle Scholar
  40. Yehuda S: Omega – 6/Omega – 3 Ratio and brain-related functions. World Rev Nutr Diet. 2003, 92: 37-56.View ArticlePubMedGoogle Scholar
  41. Champeil-Potokar G, Denis I, Goustard-Langelier B, Alessandri JM, Guesnet P, Lavialle M: Astrocytes in culture require docosahexaenoic acid to restore the n-3/n-6 polyunsaturated fatty acid balance in their membrane phospholipids. J Neurosci Res. 2004, 75: 96-106. 10.1002/jnr.10817View ArticlePubMedGoogle Scholar
  42. Hoffman PN, Griffin JW, Koo EH, Muma NA, Price DL: Neurofilaments, axonal caliber, perikaryal size. Aging and the brain. Edited by: Terry RD. 1988, 205-217. New York: Raven Press.Google Scholar
  43. Garofalo L, Ribeiro-da-Silva A, Cuello AC: Nerve growth factorinduced synaptogenesis and hypertrophy of cortical cholinergic terminals. Proc Natl Acad Sci USA. 1992, 89: 2639-2643. 10.1073/pnas.89.7.2639PubMed CentralView ArticlePubMedGoogle Scholar
  44. Purves D, Snider WD, Voyvodic JT: Trophic regulation of nerve cell morphology and innervation in the autonomic nervous system. Nature. 1988, 336: 123-128. 10.1038/336123a0View ArticlePubMedGoogle Scholar
  45. Smith TD, Adams MM, Gallagher M, Morrison JH, Rapp R: Circuit-specific alterations in hippocampal synaptophysin immunoreactivity predict spatial learning impairment in aged rats. Neuroscience. 2000, 20 (17): 6587-6593.PubMedGoogle Scholar
  46. Martin DS, Spencer P, Horrobin DF, Lynch MA: Long-term potentiation in aged rats is restored when the age-related decrease in polyunsaturated fatty acid concentration is reversed. Prostaglandins Leukot Essent Fatty Acids. 2002, 67: 121-130. 10.1054/plef.2002.0408View ArticlePubMedGoogle Scholar
  47. Hama H, Hara C, Yamaguchi K, Miyawaki A: PKC signaling mediates global enhancement of excitatory synaptogenesis in nerons triggered by local contact with astrocytes. Neuron. 2004, 41: 405-415. 10.1016/S0896-6273(04)00007-8View ArticlePubMedGoogle Scholar
  48. Corriveau RA: Electrical activity and gene expression in the development of vertebrate neural circuits. J Neurobiol. 1999, 41: 148-157. 10.1002/(SICI)1097-4695(199910)41:1<148::AID-NEU18>3.0.CO;2-6View ArticlePubMedGoogle Scholar
  49. Wu A, Ying Z, Gomez-Pinilla F: Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience. 2008, 1553: 751-759.View ArticleGoogle Scholar
  50. Janz R, Sudhof TC, Hammer RE, Unni V, Siegelbaum SA, Bolshakov VY: Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I. Neuron. 1999, 24: 687-700. 10.1016/S0896-6273(00)81122-8View ArticlePubMedGoogle Scholar
  51. Bate C, Tayebi M, Salmona M, Diomede L, Williams A: Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro. Neurotox Res. 2010, 17: 203-214. 10.1007/s12640-009-9093-2View ArticlePubMedGoogle Scholar
  52. Folch J, Lees M, Sloane Stanely GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957, 226: 497-509.PubMedGoogle Scholar
  53. Ebrahimi M, Rajion MA, Goh YM, Sazili AQ, Schonewille JT: Effect of linseed oil dietary supplementation on fatty acid composition and gene expression in adipose tissue of growing goats. Biomed Res Int. 2013, 2013: 1-11.View ArticleGoogle Scholar
  54. Paxinos G, Watson C: The rat brain in stereotaxic coordinates. 1986, London: Academic.Google Scholar

Copyright

© Hajjar et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement